Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test whether atorvastatin (also known as Lipitor) has
anti-inflammatory effects in people with no known heart disease or high cholesterol. We also
are investigating whether or not genetic differences between people plays a role in the drug
response.
Phase:
Phase 4
Details
Lead Sponsor:
University of Florida
Collaborators:
American College of Clinical Pharmacy American Heart Association